Apolipoprotein B: Not just a biomarker but a causal factor in hepatic endoplasmic reticulum stress and insulin resistance

Clinical Lipidology

Volumn 5, Issue 2, 2010, Pages 267-276

  Su, Qiaozhu ^a   Rutledge, Angela C ^a,b   Dekker, Mark ^a   Adeli, Khosrow ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

ApoB; Dyslipidemia; Endoplasmic reticulum stress; Insulin resistance; Lipid; Unfolded protein response

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; APOLIPOPROTEIN B; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BIOLOGICAL MARKER; BMS 201038; FATTY ACID; I KAPPA B KINASE INHIBITOR; INSULIN; METFORMIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR; MIPOMERSEN; PROTEIN KINASE R; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; X BOX BINDING PROTEIN 1;

CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG MECHANISM; DYSLIPIDEMIA; ENDOPLASMIC RETICULUM STRESS; FAMILIAL HYPERCHOLESTEROLEMIA; FATTY ACID TRANSPORT; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIPOGENESIS; LIVER; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW; SIGNAL TRANSDUCTION;

EID: 77950289592     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/clp.10.15     Document Type: Review

References (79)

1. Adeli K, Lewis GF: Intestinal lipoprotein overproduction in insulin-resistant states. Curr. Opin. Lipidol. 19(3), 221-228 (2008).
2. Ginsberg HN, Zhang YL, Hernandez-Ono A: Metabolic syndrome: focus on dyslipidemia. Obesity (Silver Spring) 14(Suppl. 14), S1-S49 (2006).
3. Adiels M, Olofsson SO, Taskinen MR, Boren J: Diabetic dyslipidaemia. Curr. Opin. Lipidol. 17(3), 238-246 (2006).
4. Verges B: Diabetic dyslipidaemia: insights for optimizing patient management. Curr. Med. Res. Opin. 21(Suppl. 1), S29-S40 (2005).
5. Avramoglu RK, Basciano H, Adeli K: Lipid and lipoprotein dysregulation in insulin resistant states. Clin. Chim. Acta 368(1-2), 1-19 (2006).
6. Ginsberg HN, Zhang YL, Hernandez-Ono A: Regulation of plasma triglycerides in insulin resistance and diabetes. Arch. Med. Res. 36(3), 232-240 (2005).
7. Ota T, Gayet C, Ginsberg HN: Inhibition of Apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J. Clin. Invest. 118(1), 316-332 (2008).
8. Ozawa K, Miyazaki M, Matsuhisa M et al.: The endoplasmic reticulum chaperone improves insulin resistance in Type 2 diabetes. Diabetes 54(3), 657-663 (2005).
9. Ozcan U, Cao Q, Yilmaz E et al.: Endoplasmic reticulum stress links obesity, insulin action, and Type 2 diabetes. Science 306(5695), 457-461 (2004).
10. Ron D, Walter P: Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8(7), 519-529 (2007).
11. Mori K: Signalling pathways in the unfolded protein response: development from yeast to mammals. J. Biochem. 146(6), 743-750 (2009).
12. Lee AH, Scapa EF, Cohen DE, Glimcher LH: Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 320(5882), 1492-1496 (2008).
13. Oyadomari S, Harding HP, Zhang Y, Oyadomari M, Ron D: Dephosphorylation of translation initiation factor 2a enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab. 7(6), 520-532 (2008).
14. Rutkowski DT, Wu J, Back SH et al.: UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. Dev. Cell. 15(6), 829-840 (2008).
15. Wu J, Rutkowski DT, Dubois M et al.: ATF6a optimizes long-term endoplasmic reticulum function to protect cells from chronic stress. Dev. Cell. 13(3), 351-364 (2007).
16. Schroder M, Kaufman RJ: ER stress and the unfolded protein response. Mutat. Res. 569(1-2), 29-63 (2005).
17. Harding HP, Zhang Y, Zeng H et al.: An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell. 11(3), 619-633 (2003).
18. Cox JS, Walter P: A novel mechanism for regulating activity of a transcription factor that controls the unfolded protein response. Cell 87(3), 391-404 (1996).
19. Sidrauski C, Walter P: The transmembrane kinase Ire1p is a site-specific endonuclease that initiates mRNA splicing in the unfolded protein response. Cell 90(6), 1031-1039 (1997).
20. Calfon M, Zeng H, Urano F et al.: IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415(6867), 92-96 (2002).
21. Tirasophon W, Welihinda AA, Kaufman RJ: A stress response pathway from the endoplasmic reticulum to the nucleus requires a novel bifunctional protein kinase/ endoribonuclease (Ire1p) in mammalian cells. Genes Dev. 12(12), 1812-1824 (1998).
22. Yamamoto K, Sato T, Matsui T et al.: Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6a and XBP1. Dev. Cell. 13(3), 365-376 (2007) .
23. Lee AH, Glimcher LH: Intersection of the unfolded protein response and hepatic lipid metabolism. Cell Mol. Life Sci. 66(17), 2835-2850 (2009).
24. Shaffer AL, Shapiro-Shelef M, Iwakoshi NN et al.: XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21(1), 81-93 (2004).
25. Sriburi R, Jackowski S, Mori K, Brewer JW: XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. J. Cell Biol. 167(1), 35-41 (2004).
26. Sriburi R, Bommiasamy H, Buldak GL et al.: Coordinate regulation of phospholipid biosynthesis and secretory pathway gene expression in XBP-1(S)-induced endoplasmic reticulum biogenesis. J. Biol. Chem. 282(10), 7024-7034 (2007).
27. Lu PD, Harding HP, Ron D: Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J. Cell Biol. 167(1), 27-33 (2004).
28. Millward CA, Heaney JD, Sinasac DS et al.: Mice with a deletion in the gene for CCAAT/ enhancer-binding protein b are protected against diet-induced obesity. Diabetes 56(1), 161-167 (2007).
29. Schroeder-Gloeckler JM, Rahman SM, Janssen RC et al.: CCAAT/enhancer-binding protein b deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice. J. Biol. Chem. 282(21), 15717-15729 (2007).
30. Chen C, Dudenhausen EE, Pan YX, Zhong C, Kilberg MS: Human CCAAT/enhancer-binding protein b gene expression is activated by endoplasmic reticulum stress through an unfolded protein response element downstream of the protein coding sequence. J. Biol. Chem. 279(27), 27948-27956 (2004).
31. Postic C: Apollinare Bochardat Prize 2007. Regulation and glucose signal transduction in the liver: implication of the transcription factor CHREBP. J. Annu. Diabetol. Hotel Dieu 149-159 (2007).
32. Bobrovnikova-Marjon E, Hatzivassiliou G, Grigoriadou C et al.: PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation. Proc. Natl Acad. Sci. USA 105(42), 16314-16319 (2008).
33. Colgan SM, Tang D, Werstuck GH, Austin RC: Endoplasmic reticulum stress causes the activation of sterol regulatory element binding protein-2. Int. J. Biochem. Cell Biol. 39(10), 1843-1851 (2007).
34. Lee JN, Ye J: Proteolytic activation of sterol regulatory element-binding protein induced by cellular stress through depletion of Insig-1. J. Biol. Chem. 279(43), 45257-45265 (2004).
35. Novoa I, Zeng H, Harding HP, Ron D: Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2a. J. Cell Biol. 153(5), 1011-1022 (2001).
36. Ye J, Rawson RB, Komuro R et al.: ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol. Cell. 6(6), 1355-1364 (2000).
37. Zhang K, Shen X, Wu J et al.: Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 124(3), 587-599 (2006).
38. Lee K, Tirasophon W, Shen X et al.: IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev. 16(4), 452-466 (2002).
39. Zeng L, Lu M, Mori K et al.: ATF6 modulates SREBP2-mediated lipogenesis. EMBO J. 23(4), 950-958 (2004).
40. Meex SJ, Weissglas-Volkov D, van der Kallen CJ et al.: The ATF6-Met67Val substitution is associated with increased plasma cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 29(9), 1322-1327 (2009).
41. Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F: SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86(11), 839-848 (2004).
42. Hitoshi S: Lipid synthetic transcription factor, SREBP. Nippon Rinsho 63(5), 897-907 (2005).
43. Kammoun HL, Chabanon H, Hainault I et al.: GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J. Clin. Invest. 119(5), 1201-1215 (2009).
44. Lei X, Zhang S, Barbour SE et al.: Spontaneous development of ER stress that can lead to diabetes mellitus is associated with higher calcium-independent phospholipase A2 (iPLA2b) expression: a role for regulation by SREBP-1. J. Biol. Chem. (2009).
45. Olofsson SO, Boren J: Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. J. Intern. Med. 258(5), 395-410 (2005).
46. Cnop M, Ladriere L, Hekerman P et al.: Selective inhibition of eukaryotic translation initiation factor 2 a dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic b-cell dysfunction and apoptosis. J. Biol. Chem. 282(6), 3989-3997 (2007).
47. Karaskov E, Scott C, Zhang L, Teodoro T, Ravazzola M, Volchuk A: Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic b-cell apoptosis. Endocrinology 147(7), 3398-3407 (2006).
48. Borradaile NM, Han X, Harp JD, Gale SE, Ory DS, Schaffer JE: Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J. Lipid Res. 47(12), 2726-2737 (2006).
49. Yong W, Zheng W, Zhu J et al.: Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of l-asparaginase based regimen, and prognostic factors. Hematol. Oncol. 24(1), 28-32 (2006).
50. Wang D, Wei Y, Pagliassotti MJ: Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology. 147(2), 943-951 (2006).
51. Liao W, Hui TY, Young SG, Davis RA: Blocking microsomal triglyceride transfer protein interferes with ApoB secretion without causing retention or stress in the ER. J. Lipid Res. 44(5), 978-985 (2003).
52. Bjorkegren J, Beigneux A, Bergo MO, Maher JJ, Young SG: Blocking the secretion of hepatic very low density lipoproteins renders the liver more susceptible to toxin-induced injury. J. Biol. Chem. 277(7), 5476-5483 (2002).
53. Hussain MM, Shi J, Dreizen P: Microsomal triglyceride transfer protein and its role in ApoB-lipoprotein assembly. J. Lipid Res. 44(1), 22-32 (2003).
54. Pan M, Liang JS, Fisher EA, Ginsberg HN: The late addition of core lipids to nascent apolipoprotein B100, resulting in the assembly and secretion of triglyceride-rich lipoproteins, is independent of both microsomal triglyceride transfer protein activity and new triglyceride synthesis. J. Biol. Chem. 277(6), 4413-4421 (2002).
55. Brodsky JL, Fisher EA: The many intersecting pathways underlying apolipoprotein B secretion and degradation. Trends Endocrinol. Metab. 19(7), 254-259 (2008).
56. Ginsberg HN, Fisher EA: The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism. J. Lipid Res. 50(Suppl.) S162-S166 (2009).
57. Gordon DA, Jamil H: Progress towards understanding the role of microsomal triglyceride transfer protein in Apolipoprotein-B lipoprotein assembly. Biochim. Biophys. Acta 1486(1), 72-83 (2000).
58. Cuchel M, Bloedon LT, Szapary PO et al.: Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N. Engl. J. Med. 356(2), 148-156 (2007).
59. Fisher EA, Ginsberg HN: Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins. J. Biol. Chem. 277(20), 17377-17380 (2002).
60. Taghibiglou C, Carpentier A, Van Iderstine SC et al.: Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J. Biol. Chem. 275(12), 8416-8425 (2000).
61. Su Q, Tsai J, Xu E et al.: Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance. Hepatology 50(1), 77-84 (2009).
62. Vukmirica J, Nishimaki-Mogami T, Tran K et al.: The N-linked oligosaccharides at the amino terminus of human ApoB are important for the assembly and secretion of VLDL. J. Lipid Res. 43(9), 1496-1507 (2002).
63. Bjelik A, Bereczki E, Gonda S et al.: Human ApoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis. Neurochem. Int. 49(4), 393-400 (2006).
64. Zhong S, Magnolo AL, Sundaram M et al.: Nonsynonymous mutations within APOB in human familial hypo-b-lipoproteinemia - evidence for feedback inhibition of lipogenesis and post-endoplasmic reticulum degradation of Apolipoprotein B. J. Biol. Chem. DOI: 10.1074/jbc.M109.060467. (2009) (Epub ahead of print).
65. Urano F, Wang X, Bertolotti A et al.: Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287(5453), 664-666 (2000).
66. Hu P, Han Z, Couvillon AD, Kaufman RJ, Exton JH: Autocrine tumor necrosis factor a links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1a-mediated NF-kB activation and down-regulation of TRAF2 expression. Mol. Cell Biol. 26(8), 3071-3084 (2006).
67. Aguirre V, Uchida T, Yenush L, Davis R, White MF: The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 275(12), 9047-9054 (2000).
68. Aguirre V, Stylopoulos N, Grinbaum R, Kaplan LM: An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity. Obesity (Silver Spring) 16(12), 2585-2592 (2008).
69. Lewis GF, Carpentier A, Adeli K, Giacca A: Disordered fat storage and mobilization in the pathogenesis of insulin resistance and Type 2 diabetes. Endocr. Rev. 23(2), 201-229 (2002).
70. Malmstrom R, Packard CJ, Caslake M et al.: Effects of insulin and acipimox on VLDL1 and VLDL2 Apolipoprotein B production in normal subjects. Diabetes 47(5), 779-787 (1998).
71. Arner P: Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract. Res. Clin. Endocrinol. Metab. 19(4), 471-482 (2005).
72. Howell JJ, Stoffel M: Nuclear export-independent inhibition of Foxa2 by insulin. J. Biol. Chem. 284(37), 24816-24824 (2009).
73. Kamagate A, Dong HH: FoxO1 integrates insulin signaling to VLDL production. Cell Cycle 7(20), 3162-3170 (2008).
74. Qin B, Anderson RA, Adeli K: Tumor necrosis factor-a directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling. Am. J. Physiol Gastrointest. Liver Physiol. 294(5), G1120-G1129 (2008).
75. Tsai J, Zhang R, Qiu W, Su Q, Naples M, Adeli K: Inflammatory NF-kB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production. Am. J. Physiol Gastrointest. Liver Physiol. 296(6), G1287-G1298 (2009).
76. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL: Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6(1), 77-86 (2000).
77. Blanquart C, Gonzalez-Yanes C, Issad T: Monitoring the activation state of insulin/ insulin-like growth factor-1 hybrid receptors using bioluminescence resonance energy transfer. Mol. Pharmacol. 70(5), 1802-1811 (2006).
78. Yu RZ, Lemonidis KM, Graham MJ et al.: Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100. Biochem. Pharmacol. 77(5), 910-919 (2009).
79. Kim DS, Jeong SK, Kim HR, Kim DS, Chae SW, Chae HJ: Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells. Immunopharmacol. Immunotoxicol. DOI: 10.3109/08923970903252220 (2009) (Epub ahead of print).